WVU Cancer Institute - Near-Miss Award
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Purpose: Fund additional data collection to strengthen the resubmission of a cancer-related NIH grant application.
Focus: Strengthening previously submitted cancer research proposals for resubmission to NIH.
Eligibility: Researchers with cancer-related NIH proposals that require revision and resubmission
Note: Specific award amounts, deadlines, and detailed application procedures are not provided on the pages reviewed. Contact WVU Cancer Institute for more information.
What West Virginia University Research Corporation actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 150
- Total given
- $30.3M
- Median grant
- $63K
- Range
- $5,488–$7.46M
- By dollars: West Virginia 49%, Colorado 14%, California 4%. Top recipient cities: Morgantown, WV; Charleston, WV; Pittsburgh, PA.
- 0% of grants with a stated purpose were for general or operating support.
- 23% of recipients were new grantees, not repeat recipients.
Example grants
West Virginia University · Morgantown, WV
Expenditures on grants awarded to wvurc on behalf of wvu for acquisition of capital…
$7.46M
The Stratagem Group LLC · Aurora, CO
Research
$3.33M
Marshall Univ Research Corp · Huntington, WV
Public service, research, and other
$2.3M
Intrack Radar Technologies Inc · Colorado Springs, CO
Research
$739K
Cabin Creek Health Systems Inc · Dawes, WV
Instruction and research
$633K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
Ready to apply for WVU Cancer Institute - Near-Miss Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found WVU Cancer Institute - Near-Miss Award. Now let's win it.